Coeliac Disease
Summary
Coeliac disease is a chronic autoimmune enteropathy triggered by dietary gluten in genetically susceptible individuals (HLA-DQ2/DQ8). It causes inflammation and villous atrophy in the small intestine, leading to malabsorption. The condition affects approximately 1% of the population, though many cases remain undiagnosed. Symptoms range from classic diarrhoea and weight loss to atypical presentations including anaemia, fatigue, and osteoporosis. Diagnosis requires positive serology (tissue transglutaminase IgA) followed by duodenal biopsy. Treatment is a strict lifelong gluten-free diet.
Key Facts
- Definition: Autoimmune enteropathy triggered by gluten in HLA-DQ2/DQ8-positive individuals
- Prevalence: ~1% of population; many undiagnosed
- Genetics: HLA-DQ2 (95%) or HLA-DQ8 (5%) required but not sufficient
- Key Serology: tTG-IgA (first-line); remember to check total IgA
- Biopsy: Villous atrophy + crypt hyperplasia + increased IELs (Marsh classification)
- Treatment: Strict lifelong gluten-free diet (GFD)
Clinical Pearls
"Must Be Eating Gluten": Serology AND biopsy are only valid if the patient is currently eating gluten. Do NOT recommend a GFD before investigations are complete — this can cause false negatives and diagnostic difficulty.
IgA Deficiency Trap: 2-3% of coeliac patients have IgA deficiency. If total IgA is low, tTG-IgA will be falsely negative. Request IgG-based tests (tTG-IgG or DGP-IgG).
Think Beyond Gut: Many patients present with extraintestinal manifestations — unexplained iron deficiency anaemia, osteoporosis, elevated transaminases, or neurological symptoms — rather than classic GI symptoms.
Why This Matters Clinically
Coeliac disease is underdiagnosed because many patients have non-classic presentations. Untreated disease leads to serious complications including osteoporosis, infertility, and increased lymphoma risk. A correct diagnosis enables effective treatment with a gluten-free diet, improving quality of life and preventing complications.
Incidence & Prevalence
- Prevalence: ~1% worldwide (many undiagnosed)
- Iceberg Phenomenon: Diagnosed:undiagnosed ratio approximately 1:5-7
- Increasing Detection: Rising due to better awareness and testing
- Global Variation: Higher in European and Middle Eastern populations
Demographics
| Factor | Details |
|---|---|
| Age | Can present at any age; peaks in childhood and 40-60 years |
| Sex | Female:Male 2-3:1 |
| Ethnicity | More common in European descent; uncommon in East Asia |
| At-Risk Groups | First-degree relatives (10x risk), Type 1 DM, Autoimmune thyroid, Down/Turner syndrome |
Risk Factors
Genetic:
- HLA-DQ2 (95% of patients)
- HLA-DQ8 (5%)
- 10% risk if first-degree relative affected
Associated Conditions:
| Condition | Prevalence in Coeliac |
|---|---|
| Type 1 Diabetes | 8% |
| Autoimmune thyroiditis | 10-15% |
| IgA deficiency | 2-3% |
| Down syndrome | 5-12% |
| Turner syndrome | 2-5% |
| Dermatitis herpetiformis | 25% (skin manifestation of coeliac) |
Mechanism
Step 1: Gluten Ingestion
- Gluten proteins (gliadin) from wheat, barley, rye
- Partially digested in intestine
Step 2: Epithelial Damage & Permeability
- Gliadin peptides cross epithelium via paracellular or transcellular routes
- Zonulin increases intestinal permeability
Step 3: Deamidation by tTG
- Tissue transglutaminase deamidates gliadin
- Creates negatively charged peptides
Step 4: Antigen Presentation
- Modified peptides bind HLA-DQ2/DQ8 on APCs
- Presented to CD4+ T-cells
Step 5: Immune Response
- T-cell activation triggers inflammatory cascade
- Cytokines (IFN-γ, IL-21) cause:
- Villous atrophy
- Crypt hyperplasia
- Intraepithelial lymphocytosis
- B-cells produce antibodies (anti-tTG, EMA)
Classification (Marsh)
| Grade | Histological Changes | Clinical Significance |
|---|---|---|
| Marsh 0 | Normal mucosa | Rules out active coeliac |
| Marsh 1 | Increased IELs (>25/100) only | Non-specific; can be coeliac |
| Marsh 2 | Increased IELs + crypt hyperplasia | Suggestive of coeliac |
| Marsh 3a | Partial villous atrophy | Definite coeliac |
| Marsh 3b | Subtotal villous atrophy | Definite coeliac |
| Marsh 3c | Total villous atrophy | Definite coeliac (severe) |
Symptoms
Classical GI Presentation:
Non-Classical/Atypical Presentation (More Common in Adults):
Silent Coeliac Disease:
Signs
Red Flags
[!CAUTION] Red Flags — Require urgent attention:
- Refractory coeliac disease (persistent symptoms despite strict GFD >12 months)
- Unexplained weight loss with compliance
- GI bleeding, haematemesis, melaena
- Abdominal mass or lymphadenopathy (lymphoma risk)
- Persistent or worsening symptoms after initial improvement
Structured Approach
General:
- Nutritional status (BMI, muscle mass)
- Signs of anaemia (pallor, tachycardia)
- Dermatological examination
Abdominal Examination:
- Distension
- Tenderness
- Masses (rare — suggests complication)
Special Tests
| Sign | Technique | Significance |
|---|---|---|
| Pallor | Conjunctivae, palms | Anaemia (iron, folate, B12 deficiency) |
| Glossitis | Smooth, red tongue | B12/iron deficiency |
| Angular stomatitis | Cracks at mouth corners | Iron/B12 deficiency |
| Clubbing | Nail examination | Chronic malabsorption |
| Dermatitis Herpetiformis | Elbows, knees, buttocks — vesicles | Pathognomonic skin manifestation |
| Oedema | Peripheral | Hypoalbuminaemia (severe) |
First-Line (Serological)
| Test | Sensitivity | Notes |
|---|---|---|
| tTG-IgA | 95-98% | First-line; most commonly used |
| Total IgA | — | Must check — 2-3% IgA deficient |
| EMA-IgA | 95-98% | Must check IgA level; positive = pathognomonic histology |
| DGP-IgG | 90% | Use if IgA deficient |
CRITICAL: Patient MUST be eating gluten for testing to be valid.
Laboratory Tests
| Test | Purpose |
|---|---|
| FBC | Anaemia (microcytic or macrocytic) |
| Ferritin, Iron, TIBC | Iron deficiency common |
| Folate, B12 | Malabsorption |
| LFTs | Unexplained transaminitis (5-10% of coeliac) |
| Calcium, Vitamin D | Bone health / osteomalacia |
| TFTs | Associated autoimmune thyroid disease |
Imaging / Procedures
| Modality | Findings | Indication |
|---|---|---|
| OGD + Duodenal Biopsy | Villous atrophy (Marsh grading) | Confirms diagnosis in serology-positive patients |
| DEXA Scan | Osteopenia / Osteoporosis | Baseline for all newly diagnosed |
| Small Bowel MRI/CT | Lymphoma, other complications | If red flags present |
Diagnostic Criteria
NICE NG20 Guidance:
Diagnosis requires:
- Positive serology (tTG-IgA ± EMA-IgA) WHILE eating gluten
- Duodenal biopsy showing villous atrophy (Marsh 3)
Note: In children with very high tTG (>10x upper normal) + positive EMA + HLA-DQ2/DQ8 + symptoms, biopsy may be omitted (ESPGHAN criteria — not used in adults).
Management Algorithm
CONFIRMED COELIAC DISEASE
↓
┌─────────────────────────────────────────────────────┐
│ GLUTEN-FREE DIET (Lifelong) │
│ │
│ • Avoid wheat, barley, rye (and oats initially) │
│ • Corn, rice, quinoa, potato are safe │
│ • Pure oats can be reintroduced later for most │
│ • Dietitian referral ESSENTIAL │
│ • Gluten intake must be <20ppm to be "gluten-free" │
└─────────────────────────────────────────────────────┘
↓
┌─────────────────────────────────────────────────────┐
│ NUTRITIONAL SUPPORT │
│ │
│ • Monitor and correct deficiencies: │
│ - Iron, folate, B12 │
│ - Calcium, vitamin D │
│ - Zinc, copper (if symptomatic) │
│ • Consider supplements initially │
└─────────────────────────────────────────────────────┘
↓
┌─────────────────────────────────────────────────────┐
│ BONE HEALTH │
│ │
│ • DEXA scan at diagnosis (adults) │
│ • Calcium + vitamin D supplementation if indicated │
│ • Repeat DEXA if osteopenia/osteoporosis detected │
└─────────────────────────────────────────────────────┘
↓
┌─────────────────────────────────────────────────────┐
│ VACCINATION │
│ │
│ • Pneumococcal vaccine (hyposplenism) │
│ • Ensure up-to-date with all vaccines │
└─────────────────────────────────────────────────────┘
↓
MONITORING
↓
• Annual review (symptoms, dietary compliance, bloods)
• Repeat tTG-IgA (should normalise on GFD within 6-12 months)
• If persistent symptoms on strict GFD → investigate refractory coeliac
Conservative Management (Diet)
Gluten-Free Diet:
- AVOID: Wheat, barley, rye
- SAFE: Rice, corn, potato, quinoa, buckwheat, millet
- OATS: Controversy — pure oats tolerated by most, but avoid initially
- Cross-contamination: Important consideration
- Prescribable items: Gluten-free bread, flour, pasta available on NHS prescription
Dietitian Referral:
- Essential for all newly diagnosed patients
- Education on reading labels
- Avoiding cross-contamination
- Maintaining balanced diet
Monitoring
- Annual review: Symptoms, weight, adherence
- Blood tests: FBC, ferritin, tTG-IgA (should normalise), LFTs, Ca, vit D
- tTG normalisation: Usually within 6-12 months of strict GFD
Refractory Coeliac Disease
- Defined as persistent symptoms despite strict GFD for >12 months
- Confirm dietary compliance (dietitian review, inadvertent gluten)
- Type 1: Normal IEL population — better prognosis
- Type 2: Aberrant IEL clone — increased lymphoma risk
- Refer to specialist centre
Nutritional
- Iron deficiency anaemia (most common)
- Folate and B12 deficiency
- Vitamin D and calcium deficiency
- Osteoporosis / osteomalacia
Malignancy
| Complication | Risk | Notes |
|---|---|---|
| EATL (Enteropathy-Associated T-cell Lymphoma) | 6-10x increased | Most serious; associated with refractory Type 2 |
| Small bowel adenocarcinoma | Increased | Rare |
| Oesophageal/oropharyngeal SCC | Increased | Small increase |
Other
- Hyposplenism: Functional; risk of encapsulated organism sepsis (pneumococcal vaccination)
- Dermatitis herpetiformis: Skin manifestation; responds to GFD and dapsone
- Subfertility / recurrent miscarriage: Improves with GFD
- Neurological: Peripheral neuropathy, ataxia
Natural History
With strict adherence to a gluten-free diet, most patients achieve complete symptom resolution and mucosal healing. Untreated coeliac disease leads to progressive malnutrition and increased risk of serious complications including lymphoma.
Outcomes with Treatment
| Variable | Outcome |
|---|---|
| Symptom resolution | 70-80% within weeks-months |
| Mucosal healing | 60-80% within 2-5 years |
| Serology normalisation | Usually within 6-12 months |
| Bone density improvement | Improves with GFD + supplements |
| Lymphoma risk on GFD | Returns toward general population |
Prognostic Factors
Good Prognosis:
- Strict dietary compliance
- Younger age at diagnosis
- Classic presentation (responds well to GFD)
- Serology and histology normalise
Poor Prognosis:
- Refractory coeliac disease (Type 2)
- Older age at diagnosis
- Severe malnutrition at presentation
- Non-compliance with GFD
Key Guidelines
-
NICE NG20: Coeliac Disease (2015) — Comprehensive UK guidance on recognition, diagnosis, and management.
-
BSG Guidelines (2014) — British Society of Gastroenterology guidance on testing, biopsy, and follow-up.
Landmark Studies
Ludvigsson et al. (2013) — Lancet
- Large population-based study
- Key finding: Coeliac disease associated with increased mortality, driven by malignancy
- Clinical Impact: Emphasises importance of diagnosis and treatment
Leffler & Schuppan (2010) — Update on Coeliac Disease
- Comprehensive review of pathophysiology and management
- Clinical Impact: Established modern understanding of disease mechanism
Evidence Strength
| Intervention | Level | Key Evidence |
|---|---|---|
| tTG-IgA for diagnosis | 1a | Systematic reviews, NICE |
| Gluten-free diet | 1a | Multiple studies showing symptom resolution |
| DEXA screening | 2b | Cohort studies |
| Pneumococcal vaccination | 2b | Observational (hyposplenism risk) |
What is Coeliac Disease?
Coeliac disease is a condition where your immune system reacts abnormally to gluten — a protein found in wheat, barley, and rye. When you eat gluten, your immune system attacks the lining of your small intestine, damaging it and making it difficult to absorb nutrients from food.
Why does it matter?
Without treatment, coeliac disease can cause serious problems:
- Anaemia (low iron levels)
- Weak bones (osteoporosis)
- Tiredness and feeling unwell
- Long-term, slightly increased risk of some cancers
The good news is that treatment is very effective. With a gluten-free diet, the gut heals and most people feel completely better.
How is it treated?
-
Gluten-free diet for life: You need to completely avoid wheat, barley, and rye. This means avoiding most breads, pasta, cereals, cakes, and biscuits unless they're specifically gluten-free.
-
Safe foods: Rice, potatoes, corn, quinoa, meat, fish, eggs, fruit, and vegetables are naturally gluten-free.
-
Dietitian support: You'll be referred to a dietitian who will teach you how to read food labels and avoid hidden gluten.
-
Supplements: You may need iron, vitamin D, or calcium supplements initially if you have deficiencies.
-
Prescriptions: In the UK, you can get some gluten-free staples (bread, flour, pasta) on prescription.
What to expect
- Symptoms often improve within weeks of starting a gluten-free diet
- Complete gut healing can take 1-2 years
- Annual blood tests and check-ups to make sure you're staying healthy
- You'll need to follow the diet for life — even small amounts of gluten can cause damage
When to seek help
See a doctor if:
- Symptoms don't improve on gluten-free diet
- You're losing weight unexpectedly
- You have new or worsening symptoms
- You're struggling to follow the diet
Primary Guidelines
- National Institute for Health and Care Excellence. Coeliac disease: recognition, assessment and management (NG20). 2015. nice.org.uk/guidance/ng20
Key Studies
-
Ludvigsson JF, Bai JC, Biagi F, et al. Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology. Gut. 2014;63(8):1210-1228. PMID: 24917550
-
Ludvigsson JF, Montgomery SM, Ekbom A, Brandt L, Granath F. Small-intestinal histopathology and mortality risk in celiac disease. JAMA. 2009;302(11):1171-1178. PMID: 19755695
-
Green PH, Cellier C. Celiac disease. N Engl J Med. 2007;357(17):1731-1743. PMID: 17960014
Further Resources
- Coeliac UK: coeliac.org.uk
- NICE CKS: cks.nice.org.uk
Medical Disclaimer: MedVellum content is for educational purposes and clinical reference. Clinical decisions should account for individual patient circumstances. Always consult appropriate guidelines and specialists for patient care.